Plenary Session 6 New Alternative Therapies for Refractory Heart Failure
Seiji Takashima, Hiroshi Okamoto, Masafumi Yano,
Shinji Tomita
Figure 5. AdexCTLA-4IgG
pre-treatment reduced the size of the infarcted and affected
area in a model of ischemic/reperfusion injury after cardiac
transplantation, while pre-treatment with AdexLacZ was associated
with a novel 40% infarcted area and a novel 30% affected area.
